MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
0.7665
+0.0104 (1.38%)
Aug 27, 2026, 11:14 AM EDT - Market open

MDxHealth Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, MDxHealth stock has a consensus rating of "Buy" and an average price target of $1.80. The average 1-year stock price forecast is 134.83% higher than the current stock price, while the lowest is $1.00 (+30.46%) and the highest is $3.00 (+291.39%).

Price Target: $1.80 (+134.83%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$1.00$1.80$2.00$3.00
Change+30.46%+134.83%+160.93%+291.39%

Analyst Ratings

The average analyst rating for MDxHealth stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy665444
Buy000000
Hold001222
Sell000000
Strong Sell000000
Total666666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BTIG
BTIG
Buy
Reiterates
$4$2
BuyReiterates$4$2+160.93%Aug 21, 2026
William Blair
William Blair
Hold
Reiterates
n/a
HoldReiteratesn/an/aAug 14, 2026
TD Cowen
TD Cowen
Buy
Maintains
$1
BuyMaintains$1+30.46%Aug 13, 2026
Lake Street
Lake Street
Buy
Maintains
$9$5
BuyMaintains$9$5+552.32%May 14, 2026
Craig-Hallum
Craig-Hallum
Buy
Maintains
$3
BuyMaintains$3+291.39%May 14, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
113.70M
from 107.88M
Increased by 5.40%
Revenue Next Year
128.39M
from 113.70M
Increased by 12.92%
EPS This Year
-0.54
from -0.51
EPS Next Year
-0.45
from -0.54
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
22.24M37.05M70.19M90.05M107.88M113.70M
Revenue Growth
20.47%66.62%89.43%28.29%19.80%5.40%
Gross Profit
10.56M19.22M43.93M55.14M69.63M73.14M
Gross Margin
47.50%51.87%62.58%61.23%64.55%64.33%
Operating Income
-27.88M-38.49M-27.33M-24.72M-14.41M-18.68M
Net Income
-29.00M-44.04M-43.10M-38.07M-33.52M-34.86M
EPS
-----0.51-0.54
Free Cash Flow
-14.46M-24.28M-19.28M6.67M-3.66M-9.40M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High115.3M
Avg113.7M
Low112.6M

Revenue Growth

Revenue Growth202620272028
High
6.9%
Avg
5.4%
Low
4.4%

EPS Forecast

EPS202620272028
High-0.54
Avg-0.54
Low-0.54

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-